DRDCX
Price
$24.39
Change
+$0.15 (+0.62%)
Updated
Apr 17 closing price
Net Assets
584.05M
FXAIX
Price
$183.49
Change
+$0.25 (+0.14%)
Updated
Apr 17 closing price
Net Assets
597.55B
Ad is loading...

DRDCX vs FXAIX

Header iconDRDCX vs FXAIX Comparison
Open Charts DRDCX vs FXAIXBanner chart's image
Dearborn Partners Rising Dividend C
Price$24.39
Change+$0.15 (+0.62%)
VolumeN/A
Net Assets584.05M
Fidelity 500 Index
Price$183.49
Change+$0.25 (+0.14%)
VolumeN/A
Net Assets597.55B
DRDCX vs FXAIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DRDCX vs. FXAIX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRDCX is a Buy and FXAIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 598B vs. DRDCX (584M). FXAIX pays higher dividends than DRDCX: FXAIX (1.30) vs DRDCX (0.00). DRDCX was incepted earlier than FXAIX: DRDCX (12 years) vs FXAIX (14 years). DRDCX (2.03) is less costly to investors than FXAIX (0.01). DRDCX is a more actively managed with annual turnover of: 17.53 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than DRDCX: FXAIX (0) vs DRDCX (5000). FXAIX annual gain was more profitable for investors over the last year : 6.45 vs. DRDCX (5.53). FXAIX return over 5 years is better than : 98.09 vs. DRDCX (50.39).
DRDCXFXAIXDRDCX / FXAIX
Total Expense Ratio1.950.0113,000%
Annual Report Gross Expense Ratio2.030.0113,533%
Fund Existence12 years14 years-
Gain YTD-1.823-9.97418%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets584M598B0%
Annual Yield % from dividends0.001.30-
Returns for 1 year5.536.4586%
Returns for 3 years11.1325.7643%
Returns for 5 years50.3998.0951%
Returns for 10 years101.29174.8658%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GBEMX19.01N/A
N/A
Victory Sophus Emerging Markets A
GSYPX34.98N/A
N/A
Goldman Sachs Small Cap Value P
SQCBX12.26N/A
N/A
X-Square Balanced Fund, LLC C
GEMIX22.35N/A
N/A
Goldman Sachs Emerging Markets Eq Instl
TRZSX13.02N/A
N/A
T. Rowe Price Overseas Stock Z